Core Viewpoint - A serious fire occurred in Hong Kong's Tai Po district, leading to multiple casualties and the urgent evacuation of over a thousand residents, prompting significant public concern [1] Group 1: Company Response - Lanzhou Foci Pharmaceutical Co., Ltd. (佛慈制药) coordinated with its subsidiary, Hong Kong Foci Pharmaceutical Co., Ltd., to donate 1,800 boxes of "Foci Mingshan Qingqi Huatan Wan" to assist affected residents in alleviating symptoms [1] - The company activated its public welfare emergency mechanism immediately after the fire, ensuring efficient aid delivery while assessing the safety of employees and local community residents [1] - The Hong Kong subsidiary collaborated with local rescue organizations and traditional Chinese medicine experts to address common respiratory symptoms among the affected population [1] Group 2: Aid Distribution - The selected aid product, "Foci Mingshan Qingqi Huatan Wan," was identified for its effectiveness in clearing lung phlegm and relieving respiratory discomfort [1] - The emergency supplies were successfully delivered to a designated disaster relief point on November 27, where they were distributed to affected individuals by staff and volunteers [1] - The company expressed its commitment to continue monitoring the progress of post-disaster reconstruction in Hong Kong and to support the local community [2]

Core Viewpoint - The company, Lanzhou Foci Pharmaceutical Co., Ltd., has actively responded to a fire disaster in Hong Kong by providing emergency assistance and support to affected residents [1][2]. Group 1: Emergency Response - Following a level five fire in Hong Kong's Tai Po district, the company initiated its emergency response mechanism immediately [1]. - The company coordinated with its Hong Kong subsidiary to gather aid supplies for disaster relief [1]. Group 2: Local Operations and Support - The Hong Kong subsidiary conducted safety checks for employees, their families, and nearby community residents on the night of the fire [1]. - The subsidiary effectively collaborated with local rescue organizations and Chinese medicine experts to address respiratory symptoms among the affected population [1]. Group 3: Aid Distribution - The rescue team selected "Foci Mingshan Qingqi Huatan Wan," a medicine known for its lung-clearing and phlegm-reducing properties, as the aid product [1]. - On November 27, 1,800 boxes of the selected medicine were delivered to a designated shelter and distributed to affected individuals by staff and volunteers [1]. Group 4: Ongoing Commitment - The company expressed its ongoing concern for the safety of Hong Kong residents and its commitment to support the recovery efforts [2].